Scott Gottlieb, M.D. Age: 50 years Special Partner, New Enterprise Associates, Inc.’s healthcare investment team and Resident Fellow of the American Enterprise Institute. Dr. Gottlieb served as the 23rd Commissioner of the U.S. Food and Drug Administration (FDA) from 2017 to 2019.
Scott Gottlieb, M.D. | Pfizer Board Member Scott Gottlieb, M.D. Age: 50 years Special Partner, New Enterprise Associates, Inc.’s healthcare investment team and Resident Fellow of the American Enterprise Institute. Dr. Gottlieb served as the 23rd Commissioner of the U.S. Food and Drug Administration (FDA) from 2017 to 2019.
Gottlieb attended medical school at Icahn School of Medicine at Mount Sinai and completed his residency in internal medicine at the Mount Sinai Hospital. He is Jewish. Career FDA and CMS (2003–2007) Gottlieb worked for the U.S. Food and Drug Administration (FDA) from 2002 to 2003 and 2005 to 2007.
- Anna Abram
- Donald Trump
Jun 27, 2019 · Pfizer Inc. (NYSE:PFE) today announced the election of Dr. Scott Gottlieb to its Board of Directors, effective immediately. Dr. Gottlieb, age 47, was also appointed to the Regulatory and Compliance Committee and the Science and Technology Committee of Pfizer’s Board.
Scott | Pfizer Scott Gottlieb, M.D. Age: 50 years Special Partner, New Enterprise Associates, Inc.’s healthcare investment team and Resident Fellow of the American Enterprise Institute. Dr. Gottlieb served as the 23rd Commissioner of the U.S. Food and Drug Administration (FDA) from 2017 to 2019.
Jan 9, 2023 · Dr. Scott Gottlieb, a Pfizer board member and former FDA commissioner, was prominently featured in the media's coverage of the coronavirus pandemic. (Chris Usher/CBS via Getty Images) In...
Jun 27, 2019 · Scott Gottlieb, who stepped down as Food and Drug Administration Commissioner in April, will join Pfizer ’s board of directors, the company announced Thursday. Gottlieb resigned from the...
Related searches
